Fabino Life Sciences becomes 359th Company to get listed on BSE SME platform

13 Jan 2022 , 11:03 AM

Fabino Life Sciences Limited became the 359th company to get listed on the BSE SME Platform today. The company came out with an initial public offering of 9 lakh equity shares of Rs10 Each (“Equity Shares”) for Cash at a Price of Rs36 per equity share (The “Offer Price”), aggregating to Rs3.24cr.

The company has successfully completed its public issue on January 5, 2022. The response since the launch of this platform by BSE has been very positive till date.

Fabino Life Sciences Limited is Haryana based company whose registered office is at Sonipat. The company engaged in manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other wellness-focused consumer products, packing, trading and etc. Company core business is Ethical marketing of Pharmaceutical formulation & products in Domestic market through own distribution network and Sales force under own brand name, getting our Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labeling etc.

The company export wellness and FMCG products like coffee, malt powder, protein powder, hair shampoo marketed by them.
 
Mumbai based Aryaman Financial Services Limited, was the lead manager to Fabino Life Sciences Limited.

So far, 127 companies have migrated to the main board. The 358 companies listed on BSE SME Platform have raised Rs.3,793.57 crore from the market and total market capitalization of 358 companies as on January 12,2022 is Rs. 52,061.35 Crore. BSE is the market leader in this segment with a market share of 61 percent.

SEBI came out with detailed guidelines on 18th May 2010 for launching of SME Exchange/Platform. BSE was the first stock exchange to get the approval from SEBI and launch its SME platform on 13th March 2012.